Stocks and Investing
Stocks and Investing
Wed, December 1, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, November 30, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Michael Okunewitch Initiated (ATAI) at Strong Buy and Held Target at $25 on, Nov 30th, 2021
Michael Okunewitch of Maxim Group, Initiated "Atai Life Sciences N.V." (ATAI) at Strong Buy and Held Target at $25 on, Nov 30th, 2021.
Michael has made no other calls on ATAI in the last 4 months.
There are 6 other peers that have a rating on ATAI. Out of the 6 peers that are also analyzing ATAI, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $17 on, Tuesday, November 16th, 2021
These are the ratings of the 5 analyists that currently disagree with Michael
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $50 on, Monday, November 22nd, 2021
- Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $24 on, Tuesday, November 16th, 2021
- Elemer Piros of "Roth Capital" Initiated at Strong Buy and Held Target at $32 on, Thursday, November 11th, 2021
- Andrew Tsai of "Jefferies" Initiated at Strong Buy and Held Target at $27 on, Wednesday, September 1st, 2021
- Nathan Weinstein of "Argus Research" Maintained at Strong Buy with Increased Target to $27 on, Tuesday, August 17th, 2021
Contributing Sources